Clinical trial
Study to Compare the Immunogenicity and Safety of Two HIV Preventive…
NCT00490074 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Completed
Key facts
| NCT number | NCT00490074 |
|---|---|
| Title | Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers |
| Official title | A Phase I/II Trial to Compare the Immunogenicity and Safety of 3 DNA C Prime Followed by 1 NYVAC C Boost to 2 DNA C Prime Followed by 2 NYVAC C Boost |
| Acronym | EV03/ANRSVAC20 |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Collaborators | EuroVacc Foundation |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Biological |
| Interventions | DNA-C, NYVAC-C |
| Enrollment | 147 |
| Start date | Jul 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Oct 1, 2009 |
| First posted | Jun 22, 2007 |
| Last update posted | Nov 26, 2009 |
| Countries | France, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: